Helicobacter pylori infection and monoclonal gammopathy of undetermined significance

S Vincent Rajkumar, Robert A. Kyle, Matthew F. Plevak, Joseph A Murray, Terry M Therneau

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

A recent report found resolution of monoclonal gammopathy of undetermined significance (MGUS) in nearly 30% of patients upon eradication of concomitant Helicobacter pylori (H. pylori) infection. We performed serologicalal testing for H. pylori on 93 MGUS patients and 98 control subjects. Seroprevalence of H. pylori was not significantly different between the two groups, 30% and 32% respectively. A retrospective review of Mayo Clinic records revealed identical diagnosis rates of H. pylori infection (33%) by serology, breath or stool testing between patients with MGUS and those with negative monoclonal protein studies. There was no evidence of resolution of MGUS with H. pylori therapy.

Original languageEnglish (US)
Pages (from-to)706-708
Number of pages3
JournalBritish Journal of Haematology
Volume119
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Monoclonal Gammopathy of Undetermined Significance
Helicobacter Infections
Helicobacter pylori
Seroepidemiologic Studies
Serology
Proteins

Keywords

  • Aetiology
  • Helicobacter pylori
  • Infection
  • Monoclonal gammopathy
  • Myeloma

ASJC Scopus subject areas

  • Hematology

Cite this

Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. / Rajkumar, S Vincent; Kyle, Robert A.; Plevak, Matthew F.; Murray, Joseph A; Therneau, Terry M.

In: British Journal of Haematology, Vol. 119, No. 3, 2002, p. 706-708.

Research output: Contribution to journalArticle

@article{32d0adc448fa4097ada72a3d0a87e68b,
title = "Helicobacter pylori infection and monoclonal gammopathy of undetermined significance",
abstract = "A recent report found resolution of monoclonal gammopathy of undetermined significance (MGUS) in nearly 30{\%} of patients upon eradication of concomitant Helicobacter pylori (H. pylori) infection. We performed serologicalal testing for H. pylori on 93 MGUS patients and 98 control subjects. Seroprevalence of H. pylori was not significantly different between the two groups, 30{\%} and 32{\%} respectively. A retrospective review of Mayo Clinic records revealed identical diagnosis rates of H. pylori infection (33{\%}) by serology, breath or stool testing between patients with MGUS and those with negative monoclonal protein studies. There was no evidence of resolution of MGUS with H. pylori therapy.",
keywords = "Aetiology, Helicobacter pylori, Infection, Monoclonal gammopathy, Myeloma",
author = "Rajkumar, {S Vincent} and Kyle, {Robert A.} and Plevak, {Matthew F.} and Murray, {Joseph A} and Therneau, {Terry M}",
year = "2002",
doi = "10.1046/j.1365-2141.2002.03912.x",
language = "English (US)",
volume = "119",
pages = "706--708",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Helicobacter pylori infection and monoclonal gammopathy of undetermined significance

AU - Rajkumar, S Vincent

AU - Kyle, Robert A.

AU - Plevak, Matthew F.

AU - Murray, Joseph A

AU - Therneau, Terry M

PY - 2002

Y1 - 2002

N2 - A recent report found resolution of monoclonal gammopathy of undetermined significance (MGUS) in nearly 30% of patients upon eradication of concomitant Helicobacter pylori (H. pylori) infection. We performed serologicalal testing for H. pylori on 93 MGUS patients and 98 control subjects. Seroprevalence of H. pylori was not significantly different between the two groups, 30% and 32% respectively. A retrospective review of Mayo Clinic records revealed identical diagnosis rates of H. pylori infection (33%) by serology, breath or stool testing between patients with MGUS and those with negative monoclonal protein studies. There was no evidence of resolution of MGUS with H. pylori therapy.

AB - A recent report found resolution of monoclonal gammopathy of undetermined significance (MGUS) in nearly 30% of patients upon eradication of concomitant Helicobacter pylori (H. pylori) infection. We performed serologicalal testing for H. pylori on 93 MGUS patients and 98 control subjects. Seroprevalence of H. pylori was not significantly different between the two groups, 30% and 32% respectively. A retrospective review of Mayo Clinic records revealed identical diagnosis rates of H. pylori infection (33%) by serology, breath or stool testing between patients with MGUS and those with negative monoclonal protein studies. There was no evidence of resolution of MGUS with H. pylori therapy.

KW - Aetiology

KW - Helicobacter pylori

KW - Infection

KW - Monoclonal gammopathy

KW - Myeloma

UR - http://www.scopus.com/inward/record.url?scp=0036433471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036433471&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.2002.03912.x

DO - 10.1046/j.1365-2141.2002.03912.x

M3 - Article

C2 - 12437647

AN - SCOPUS:0036433471

VL - 119

SP - 706

EP - 708

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -